Sagent To Acquire Other Half Of Kanghong Sagent JV For $25 Million
This article was originally published in PharmAsia News
Executive Summary
U.S.-based Sagent Pharmaceuticals said it plans to acquire all of China's Kanghong Sagent Pharmaceutical in a buyout estimated at $25 million and make the company a subsidiary.